Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/1997
10/07/1997US5674685 Systematic evolution of ligands bu exponential enrichment
10/07/1997US5674681 Detecting association of a nonclassical major histocompatibility complex with a beta2 microglobin
10/07/1997US5674678 Increasing production of galactosidase by culturing escherichia coli having hybrid plasmid in medium containing glucose, adding oxygen, monitoring concentration, adding indoleacrylic acid and casamino acid when oxygen increases
10/07/1997US5674500 Vaccines against Aujeszky's disease and other animal diseases containing pseudorabies virus mutants
10/07/1997US5674499 Equine herpesvirus gene 15 mutants
10/07/1997US5674492 Method of preventing or treating disease characterized by neoplastic cells expressing CD40
10/07/1997US5674485 Insect diagnostic and control compositions with truncated JHE
10/07/1997US5674484 Vaccine antigens for treatment of poultry
10/07/1997CA1339489C Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
10/05/1997CA2201806A1 Novel proteins, their production and use
10/02/1997WO1997036252A1 Computational method for designing chemical structures having common functional characteristics
10/02/1997WO1997036005A1 Oligonucleotide treatments and compositions for human melanoma
10/02/1997WO1997036004A1 Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer methastasis formation
10/02/1997WO1997035999A2 Production of vanillin
10/02/1997WO1997035998A1 Methods of modulating melanin synthesis
10/02/1997WO1997035997A2 Recombinant pox virus encoding myelin protein for therapy
10/02/1997WO1997035996A1 Packaging cell line based on human 293 cells
10/02/1997WO1997035995A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997WO1997035994A2 Cytochrome p450 transducing retroviral vectors
10/02/1997WO1997035993A2 Psa positive regulating (psar) sequences and uses thereof
10/02/1997WO1997035992A1 Tetracycline inducible/repressible systems
10/02/1997WO1997035991A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997WO1997035990A2 Histone deacetylases, and uses related thereto
10/02/1997WO1997035989A2 Cyclic nucleotide phosphodiesterase
10/02/1997WO1997035988A1 Thermostable dna-polymerase from thermococcus spec. ty
10/02/1997WO1997035987A1 Sunflower seeds with enhanced saturated fatty acid contents
10/02/1997WO1997035986A1 Nucleic acid molecules encoding cytochrome p450-type proteins involved in the brassinosteroid synthesis in plants
10/02/1997WO1997035985A1 Host cells expressing mutants of a natural g-protein coupled receptor (gpcr); saccharomyces cerevisiae ste2 gene, and their use as biosensors
10/02/1997WO1997035984A1 Plant phosphate transporter gene and method of regulating plant growth with said gene
10/02/1997WO1997035983A2 Cysteine protease promoter from oil seed rape and a method for the containment of plant germplasm
10/02/1997WO1997035982A2 Monocyte chemotactic protein-5 materials and methods
10/02/1997WO1997035981A1 Insect neuropeptides genes and peptides
10/02/1997WO1997035980A1 Antibodies against avirulence/pathogenicity proteins of plant pathogens
10/02/1997WO1997035979A1 Novel trio molecules and uses related thereto
10/02/1997WO1997035978A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
10/02/1997WO1997035977A1 Polycation-sensing receptor in aquatic species and methods of use thereof
10/02/1997WO1997035976A2 Epidermal differentiation factor
10/02/1997WO1997035975A1 E2f-like transcription repressor and dna encoding it
10/02/1997WO1997035974A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases
10/02/1997WO1997035973A2 SEQUENCES CODING FOR CANINE β2- AND β3-ADRENERGIC RECEPTORS AND APPLICATIONS THEREOF AS PROBES AND FOR THE EXPRESSION OF PEPTIDES
10/02/1997WO1997035972A1 Recombinant nucleic acid sequences coding for proteins with at least one hydrophobic domain, and uses thereof
10/02/1997WO1997035971A1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES
10/02/1997WO1997035970A1 Oligonucleotides used for detecting vibrio parahaemolyticus and method of detection therewith
10/02/1997WO1997035969A2 Peptide ligands of the urokinase receptor
10/02/1997WO1997035968A1 Compositions and methods for production of male-sterile plants
10/02/1997WO1997035967A2 Transgenic organisms with altered telomerase activity
10/02/1997WO1997035966A1 Methods and compositions for cellular and metabolic engineering
10/02/1997WO1997035965A1 Plant sugar sensors and uses thereof
10/02/1997WO1997035964A1 Fine magnetic particles containing useful proteins bound thereto, process for producing the same, and use thereof
10/02/1997WO1997035962A1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator
10/02/1997WO1997035961A1 Ubiquitination of the transcription factor e2a
10/02/1997WO1997035960A1 Purified proteins, recombinant dna sequences and processes for producing caffeine free beverages
10/02/1997WO1997035957A1 Evolving cellular dna uptake by recursive sequence recombination
10/02/1997WO1997035956A1 Alkaline protease deficient filamentous fungi
10/02/1997WO1997035887A1 Precursors of catalytic antibodies
10/02/1997WO1997035885A1 ErbB3 ANTIBODIES
10/02/1997WO1997035873A2 Peptides with antiproliferative properties
10/02/1997WO1997035870A1 Growth factor htter36
10/02/1997WO1997035620A1 Formulations of ob protein
10/02/1997WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997WO1997035616A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
10/02/1997WO1997035614A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias
10/02/1997WO1997035611A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof
10/02/1997WO1997035610A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof
10/02/1997WO1997035606A1 Macrophage stimulating protein for the treatment of gastrointestinal disorders
10/02/1997WO1997035600A1 Glycosylated amylins
10/02/1997WO1997035538A2 Tumor necrosis factor alpha convertase
10/02/1997WO1997035476A2 Use of aromatic aldehydes as insecticides and for killing arachnids
10/02/1997WO1997035471A2 Use of aromatic aldehydes as pesticides
10/02/1997WO1997035468A1 Method for transforming orchidaceous plant using agrobacterium
10/02/1997WO1997031117A3 A human cytomegalovirus combined antigen and its use
10/02/1997WO1997029201A3 Retroviral vector for the gene transfer of an il6 antagonist in human haematopoietic stem cells
10/02/1997WO1997029194A3 Preparation of l-ascorbic acid
10/02/1997WO1997029113A3 Process for preparing purified nucleic acid and the use thereof
10/02/1997WO1997027276A3 Nucleic acids encoding polypeptides having absidia lipase activity
10/02/1997WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip)
10/02/1997WO1997025416A3 Novel dna glycosylases and their use
10/02/1997WO1997024455A3 Methods and compositions for full-length cdna cloning
10/02/1997WO1997023611A3 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/02/1997WO1997020933A3 Mutational variants of mammalian ob gene proteins
10/02/1997WO1997020068A3 Method for generating multiple double stranded nucleic acids
10/02/1997WO1997020067A3 Process for detecting the expression of cd95 in cells
10/02/1997WO1997019181A3 Virus vector for the transfer of stable episomes
10/02/1997WO1997018334A3 Nucleic acid probes complementary to human papillomavirus nucleic acid and related methods and kits
10/02/1997WO1997014797A3 Cystatin m, a novel cysteine proteinase inhibitor
10/02/1997WO1997011176A3 Cyclin/cdk associated proteins, and uses related thereto
10/02/1997DE19649606C1 System for identifying substances effective against HPV-associated carcinoma
10/02/1997DE19612684A1 Neue Verwendung extrem thermophiler DNA-Polymerasen New use of extremely thermophilic DNA polymerases
10/02/1997DE19612463A1 Neues Protein mit differenzierungsinduzierender Aktivität für erythropoetische Zellen Novel protein differenzierungsinduzierender activity for erythropoietic cells
10/02/1997DE19611759A1 Thermostabile DNA-Polymerase aus Thermococcus spec. Thermostable DNA polymerase from Thermococcus spec.
10/02/1997CA2257120A1 Purified proteins, recombinant dna sequences and processes for producing caffeine free beverages
10/02/1997CA2251691A1 Peptides with antiproliferative properties
10/02/1997CA2250923A1 Oligonucleotide treatments and compositions for human melanoma
10/02/1997CA2250576A1 Monocyte chemotactic protein-5 materials and methods
10/02/1997CA2250570A1 Formulations of ob protein
10/02/1997CA2250452A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease
10/02/1997CA2250332A1 Antitumour cellular compositions expressing at least three transgenes
10/02/1997CA2250207A1 A novel mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes
10/02/1997CA2250202A1 Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer methastasis formation
10/02/1997CA2250183A1 Psa positive regulating (psar) sequences and uses thereof
1 ... 3594 3595 3596 3597 3598 3599 3600 3601 3602 3603 3604 3605 3606 3607 3608 3609 3610 3611 3612 3613 3614 ... 4023